experiments within a Caco-2 enograft model demonstrated that EpMab-16 treatment significantly reduced tumor development weighed against that in mice treated using the control mouse IgG
experiments within a Caco-2 enograft model demonstrated that EpMab-16 treatment significantly reduced tumor development weighed against that in mice treated using the control mouse IgG. Amonafide (AS1413) decreased tumor development weighed against that in mice treated using the control mouse…